title: Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C.
authors.forename: C
authors.initials: C
authors.lastname: Smirne
authors.forename: R
authors.initials: R
authors.lastname: Minisini
authors.forename: M E
authors.initials: ME
authors.lastname: Burlone
authors.forename: E
authors.initials: E
authors.lastname: Ceriani
authors.forename: F
authors.initials: F
authors.lastname: Corlianò
authors.forename: G
authors.initials: G
authors.lastname: Occhino
authors.forename: M
authors.initials: M
authors.lastname: Pirisi
mesh_terms: D001202:Ascitic Fluid / Q000737:chemistry*; D015897:Comorbidity; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000628:therapy; D008875:Middle Aged; D010530:Peritoneal Dialysis; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins